Literature DB >> 6322900

Sphincter of Oddi motility.

J Toouli.   

Abstract

Recent developments of manometric and endoscopic instrumentation have rekindled interest in sphincter of Oddi function. As a result of human and animal studies, our understanding of normal sphincter of Oddi physiology has increased and possible motility abnormalities are being identified. Manometric studies have shown that the sphincter of Oddi is characterized by prominent phasic contractions which are super-imposed on a low tonic pressure. The phasic contractions are orientated mainly in an antegrade direction; however, both simultaneous and retrograde contractions are registered. Cineradiography has demonstrated that the phasic contractions have a propulsive function, expelling small volumes of fluid from the common bile duct into the duodenum. Intravenously administered cholecystokinin-octapeptide normally inhibits the phasic contractions and reduces the sphincter tone. Motility abnormalities may occur if the sphincter of Oddi exhibits abnormally high tone, alteration in the direction of the phasic contractions, abnormal changes in the contraction frequency, or abnormal responses to hormonal stimulation. Preliminary human studies demonstrate disorders in sphincter of Oddi motility patterns, suggesting that motility abnormalities may be associated with choledocholithiasis, dyskinesia and idiopathic relapsing pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6322900     DOI: 10.1002/bjs.1800710402

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  22 in total

Review 1.  Endoscopic retrograde cholangiopancreatography in chronic pancreatitis.

Authors:  Peter J Bolan; Aaron S Fink
Journal:  World J Surg       Date:  2003-10-16       Impact factor: 3.352

2.  Effect of octreotide on human sphincter of Oddi motility following liver transplantation.

Authors:  F H Weber; R J Sears; B Kendall; T L Pruett; H A Shaffer; P Yeaton
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

3.  Ileal pouch-anal anastomosis for Crohn's disease.

Authors:  R K Phillips
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

4.  Sphincter of Oddi dysfunction and acute pancreatitis.

Authors:  J W Chen; G T Saccone; J Toouli
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

Review 5.  Biliary motility.

Authors:  P A Grace; G J Poston; R C Williamson
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

Review 6.  [Sphincter of Oddi dyskinesia].

Authors:  H-D Allescher
Journal:  Internist (Berl)       Date:  2015-06       Impact factor: 0.743

Review 7.  Treatment with Methylnaltrexone and IVIG for Paraneoplastic Gastrointestinal Dysmotility.

Authors:  Madhusudan Grover; Michael Camilleri
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-01

8.  Management of Sphincter of Oddi Dysfunction: Teaching an Old SOD New Tricks?

Authors:  Tilak Shah; Alvin Zfass; Mitchell L Schubert
Journal:  Dig Dis Sci       Date:  2016-09       Impact factor: 3.199

9.  Efficacy of nifedipine therapy in patients with sphincter of Oddi dysfunction: a prospective, double-blind, randomized, placebo-controlled, cross over trial.

Authors:  M S Khuroo; S A Zargar; G N Yattoo
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

10.  Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?

Authors:  K F Binmoeller; A G Harris; R Dumas; C Grimaldi; J P Delmont
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.